ACXP Acurx Pharmaceuticals Year-over-year earnings per share growth for the last twelve months

Official company branding of Acurx Pharmaceuticals Inc. (ACXP)

The quarterly EPS trajectory on the GURU.Markets terminal linear chart contains the value 60.70, which describes the current level. Acurx Pharmaceuticals (ACXP) develops innovative antibiotics to combat resistant infections, confirming clinical efficacy. The business relies on outsourced synthesis and tracking, operating without its own manufacturing plants. Meanwhile, contract production capacities for drug output undergo rigorous technical audits and calibration.

acurxpharma.com (ACXP) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Acurx Pharmaceuticals

- share price and expert price forecast:
Stock Price Acurx|ACXP - Consensus Target
- market capitalization data:
Market Value Acurx Pharmaceuticals, Inc.|ACXP - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Acurx Pharmaceuticals|ACXP - Total Stockholders' Equity|Market Capitalization to Book Value Ratio acurxpharma.com|ACXP - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Acurx Pharmaceuticals|ACXP - Long-Term Liabilities to Capital|Short-Term Debt to Equity Acurx Pharmaceuticals|ACXP - Company Total Debt Obligations|Debts to Book Capitalization Acurx Pharmaceuticals, Inc.|ACXP - Company Long-Term Debts|Company Short-Term Debts Acurx Pharmaceuticals|Quick Liquidity Indicator acurxpharma.com
- earnings and market multiples details:
ACXP - Net Profit|Expected Profit Acurx Pharmaceuticals|ACXP - Company Value to Net Income|Projected Price to Earnings Acurx Pharmaceuticals|ACXP - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Acurx Pharmaceuticals, Inc.|ACXP - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Acurx Pharmaceuticals|ACXP - Earnings per one share for the last 12 months|Quarterly EPS earnings growth acurxpharma.com|ACXP - Earnings per share increase in current year|Earnings growth forecast for next year Acurx Pharmaceuticals
- sales volume and revenue indicators:
ACXP - Revenue and Sales Volume|Company Projected Revenue Acurx|ACXP - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Acurx Pharmaceuticals, Inc.
Analysis of all company metrics:Acurx - ACXP
Flagship merchandise of acurxpharma.com

The stability of R&D personnel and the success of biochemical developments at Acurx Pharmaceuticals (ACXP) translate directly into net earnings per share dynamics. By analyzing the quarterly change in EPS, investors assess the speed at which intellectual capital transforms into real financial results, identifying the gap between the market price and the business's fundamental strength. The sharp fluctuations on this chart necessitate an evaluation of the company's margin of safety, eliminating emotional reactions to external shocks.

Competitor analysis

ARMP: Quarterly EPS earnings growth